4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0001209191-21-060775
Chief Executive Officer acquired 33,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kulkarni Samarth Chief Executive Officer | 2021-10-15 | Option exercise | +33,000 | $1.81 | $59,730 | 219,932 | D |
| Derivatives | |||||||
| Kulkarni Samarth Chief Executive Officer | 2021-10-15 | Grant or award · Stock Option (Right to Buy) | +43,000 | 43,000 | D | ||
| Kulkarni Samarth Chief Executive Officer | 2021-10-15 | Option exercise · Stock Option (Right to Buy) | −33,000 | 75,983 | D | ||
Loading xslF345X03/doc4.xml…